Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.92 | 1.03 | 0.11 |
Shares | 99.08 | 99.08 | 0.00 |
Other | 0.01 | 0.01 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.24 | 21.77 |
Price to Book | 4.16 | 3.99 |
Price to Sales | 2.44 | 2.26 |
Price to Cash Flow | 17.43 | 16.88 |
Dividend Yield | 1.84 | 1.35 |
5 Years Earnings Growth | 10.18 | 11.34 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.37 | 94.94 |
Basic Materials | 0.53 | 1.27 |
Financial Services | 0.05 | 8.83 |
Consumer Defensive | 0.05 | 3.86 |
Number of long holdings: 198
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.26 | 831.26 | +1.33% | |
UnitedHealth | US91324P1021 | 6.04 | 497.44 | +0.42% | |
J&J | US4781601046 | 5.07 | 147.74 | +0.73% | |
Novo Nordisk B | DK0062498333 | 4.89 | 931.0 | +0.77% | |
Merck&Co | US58933Y1055 | 4.23 | 128.42 | +2.29% | |
AbbVie | US00287Y1091 | 4.07 | 160.31 | -0.58% | |
Thermo Fisher Scientific | US8835561023 | 2.87 | 569.58 | +0.28% | |
Novartis | CH0012005267 | 2.76 | 92.82 | +0.10% | |
Abbott Labs | US0028241000 | 2.70 | 102.87 | +0.67% | |
Roche Holding Participation | CH0012032048 | 2.44 | 234.70 | +1.12% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Legal General US Index Trust F Acc | 776.83K | 8.57 | 10.85 | 15.17 | ||
Legal General US Index Trust F Dist | 20.8K | 8.55 | 10.84 | 15.16 | ||
Legal General US Index Trust I Dist | 1.64B | 7.05 | 14.13 | 15.25 | ||
Legal General US Index Trust C Acc | 3.71B | 7.11 | 14.19 | 15.31 | ||
Legal General US Index Trust C Dist | 958.82M | 7.07 | 14.19 | 15.30 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review